Ipilimumab has been associated to medication related jaw osteonecrosis (MRONJ) only two times in literature. A woman underwent therapy with ipilimumab for Metastatic Melanoma in 2015 and she developed MRONJ in 2018. She was successfully treated with medical therapy alone. Vigilance in dental management of these patients is needed.